Munich-based SME providing project management and process organization services for European health research consortia.
GABO:mi is a Munich-based SME specializing in project management, clinical trial coordination, and data management for large-scale European research consortia. Their company name — Gesellschaft für Ablauforganisation (Process Organization Company) — reflects their core business: managing complex multi-partner workflows in health and life science projects. They provide operational backbone services such as milestone tracking, regulatory compliance support, and consortium coordination, enabling research teams to focus on science while GABO:mi handles logistics. Their consistent small funding shares across diverse health topics confirm a horizontal service role rather than domain-specific research.
Managed operations for clinical and translational projects including PRECIOUS (stroke prevention trial), TREGeneration (cell therapy), HemAcure (gene therapy device), and RELENT (autoimmune disease).
Participated in 7 out of 9 projects in the health sector, consistently taking small budget shares typical of management/coordination service providers.
Supported RADAR-CNS (wearable device-based remote assessment) and SENSE-Cog (digital technology for elderly mental health), both involving digital data collection infrastructure.
Extended project management services beyond health into materials science (DIACAT, diamond photocatalysis) and nanomedicine (FOLSMART), demonstrating sector-agnostic operational capability.
GABO:mi's early H2020 projects (2015) spanned a broader range including materials science (DIACAT — CO2 photocatalysis with diamond materials), cell and gene therapy (TREGeneration, HemAcure), and clinical trials for stroke and autoimmune disease. By 2016, their portfolio narrowed sharply toward neuroscience, mental health, and digital health — with projects on dementia screening, wearable-based monitoring for epilepsy and depression (RADAR-CNS), and sensory impairment in the elderly (SENSE-Cog). This shift reflects growing demand for project management expertise in digital health trials with complex data workflows.
GABO:mi is moving toward managing digital health and remote monitoring projects, positioning them well for future EU programs focused on aging populations and decentralized clinical trials.
GABO:mi exclusively operates as a consortium participant, never as coordinator, which is consistent with a service-provider model — they support project operations rather than driving the scientific agenda. With 111 unique partners across just 9 projects, they work in large consortia (averaging 12+ partners per project) and rarely repeat partnerships, indicating they are a trusted plug-in partner sought by different research communities. Working with them means getting a reliable operational partner experienced in managing EU project administration and reporting.
Despite only 9 projects, GABO:mi has built a remarkably broad network of 111 unique partners across 22 countries, reflecting their role as a versatile service provider welcomed into diverse consortia. Their reach spans most of the EU and associated countries, with no narrow geographic bias.
GABO:mi fills a specific niche that many consortia need but few SMEs provide: professional project management and process organization for complex multi-site health research. Their company structure (Ablauforganisation = process organization) is purpose-built for this role. For consortium builders, GABO:mi offers a proven German SME partner that handles operational complexity — milestone management, reporting, regulatory workflows — so that universities and research institutes can focus on the science.
